Details for New Drug Application (NDA): 213074
✉ Email this page to a colleague
The generic ingredient in NEOSTIGMINE METHYLSULFATE is neostigmine methylsulfate. There are nine drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
Summary for 213074
Tradename: | NEOSTIGMINE METHYLSULFATE |
Applicant: | Caplin |
Ingredient: | neostigmine methylsulfate |
Patents: | 0 |
Pharmacology for NDA: 213074
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 213074
Suppliers and Packaging for NDA: 213074
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 213074 | ANDA | Caplin Steriles Limited | 65145-111 | 65145-111-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-111-10) / 10 mL in 1 VIAL, MULTI-DOSE (65145-111-01) |
NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 213074 | ANDA | Caplin Steriles Limited | 65145-112 | 65145-112-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-112-10) / 10 mL in 1 VIAL, MULTI-DOSE (65145-112-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 5MG/10ML (0.5MG/ML) | ||||
Approval Date: | Apr 20, 2021 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10MG/10ML (1MG/ML) | ||||
Approval Date: | Apr 20, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription